Royalty Pharma plc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| MORGAN STANLEY | 11/14/2025 | 44.16 M | $1.56 B | -5.24% | 10.22% |
| FMR LLC | 11/13/2025 | 27.99 M | $987.37 M | -30.65% | 6.47% |
| CAPITAL INTERNATIONAL INVESTORS | 11/13/2025 | 27.21 M | $960.06 M | 24.37% | 6.30% |
| BLACKROCK, INC. | 11/12/2025 | 26.20 M | $924.35 M | 3.03% | 6.06% |
| BAILLIE GIFFORD & CO | 10/31/2025 | 17.37 M | $612.90 M | -3.60% | 4.02% |
| SWEDBANK AB | 10/15/2025 | 12.20 M | $430.43 M | 0.35% | 2.82% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2025 | 11.97 M | $422.15 M | 99.43% | 2.77% |
| VANGUARD GROUP INC | 11/07/2025 | 10.94 M | $385.84 M | -69.94% | 2.53% |
| STATE STREET CORP | 11/14/2025 | 10.27 M | $362.42 M | 0.76% | 2.38% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 7.62 M | $268.03 M | -6.84% | 1.76% |
| CALEDONIA (PRIVATE) INVESTMENTS PTY LTD | 11/14/2025 | 7.55 M | $266.28 M | 17.11% | 1.75% |
| VICTORY CAPITAL MANAGEMENT INC | 11/12/2025 | 4.66 M | $164.31 M | 3.69% | 1.08% |
| NORTHERN TRUST CORP | 11/14/2025 | 4.08 M | $143.77 M | 1.33% | 0.94% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 11/13/2025 | 3.28 M | $115.80 M | 10.27% | 0.76% |
| JANE STREET GROUP, LLC | 11/14/2025 | 3.15 M | $111.19 M | 314.63% | 0.73% |
| UBS ASSET MANAGEMENT AMERICAS INC | 11/14/2025 | 3.13 M | $110.42 M | -23.23% | 0.72% |
| PATIENT CAPITAL MANAGEMENT, LLC | 10/30/2025 | 3.12 M | $110.00 M | 4.35% | 0.72% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 3.03 M | $106.75 M | 0.56% | 0.70% |
| NEW SOUTH CAPITAL MANAGEMENT INC | 11/06/2025 | 2.92 M | $102.96 M | 1.10% | 0.68% |
| LEGAL & GENERAL GROUP PLC | 11/13/2025 | 2.82 M | $99.58 M | 3.81% | 0.65% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 2.65 M | $93.38 M | 29.66% | 0.61% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2025 | 2.48 M | $87.56 M | 737.29% | 0.57% |
| DORSEY ASSET MANAGEMENT, LLC | 11/14/2025 | 2.35 M | $82.92 M | 100.00% | 0.54% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 2.24 M | $78.86 M | 379.20% | 0.52% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 2.10 M | $74.10 M | 10.84% | 0.49% |
| AMUNDI | 11/14/2025 | 2.07 M | $74.79 M | -26.01% | 0.48% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2025 | 1.96 M | $69.19 M | 12.95% | 0.45% |
| DEUTSCHE BANK AG\ | 11/13/2025 | 1.94 M | $68.32 M | 10.58% | 0.45% |
| HOMESTEAD ADVISERS CORP | 11/05/2025 | 1.90 M | $67.12 M | -1.91% | 0.44% |
| JPMORGAN CHASE & CO | 11/26/2025 | 1.76 M | $62.08 M | 24.49% | 0.41% |
| CLARK CAPITAL MANAGEMENT GROUP, INC. | 11/14/2025 | 1.75 M | $61.80 M | 100.00% | 0.41% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 1.65 M | $58.06 M | 326.47% | 0.38% |
| INVESCO LTD. | 11/13/2025 | 1.59 M | $56.08 M | 1.93% | 0.37% |
| UBS GROUP AG | 11/13/2025 | 1.54 M | $54.39 M | -30.14% | 0.36% |
| MITSUBISHI UFJ TRUST & BANKING CORP | 10/31/2025 | 1.52 M | $53.58 M | -11.58% | 0.35% |
| BRANDYWINE GLOBAL INVESTMENT MANAGEMENT, LLC | 11/13/2025 | 1.52 M | $53.50 M | 20.32% | 0.35% |
| GENERAL ATLANTIC, L.P. | 11/13/2025 | 1.50 M | $52.92 M | 0.00% | 0.35% |
| MARSHALL WACE, LLP | 11/13/2025 | 1.48 M | $52.34 M | 100.00% | 0.34% |
| RAYMOND JAMES FINANCIAL INC | 11/14/2025 | 1.45 M | $51.18 M | 29.06% | 0.34% |
| REGAL PARTNERS LTD | 11/13/2025 | 1.44 M | $50.63 M | 6.69% | 0.33% |
| RUSSELL INVESTMENTS GROUP, LTD. | 11/13/2025 | 1.41 M | $49.60 M | 7.55% | 0.33% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 1.27 M | $44.86 M | -3.81% | 0.29% |
| ROBECO INSTITUTIONAL ASSET MANAGEMENT B.V. | 10/22/2025 | 1.25 M | $44.05 M | 61.29% | 0.29% |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 11/14/2025 | 1.22 M | $43.19 M | -15.82% | 0.28% |
| WEDGE CAPITAL MANAGEMENT L L P/NC | 10/10/2025 | 1.19 M | $42.07 M | -1.85% | 0.28% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 1.18 M | $41.78 M | 2,089.03% | 0.27% |
| SUMITOMO MITSUI TRUST HOLDINGS, INC. | 10/27/2025 | 1.10 M | $38.87 M | 23.18% | 0.25% |
| SWISS NATIONAL BANK | 11/13/2025 | 1.09 M | $38.57 M | -1.97% | 0.25% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2025 | 1.03 M | $36.37 M | 271.87% | 0.24% |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 10/20/2025 | 1.02 M | $35.87 M | 220.99% | 0.24% |
Royalty Pharma plc institutional Ownership - FAQ's
During the previous two years, 601 institutional investors and hedge funds held shares of Royalty Pharma plc. The most heavily invested institutionals were:
MORGAN STANLEY: 44.16 M
FMR LLC: 27.99 M
Capital International Investors: 27.21 M
BlackRock, Inc.: 26.2 M
BAILLIE GIFFORD & CO: 17.37 M
Swedbank AB: 12.2 M
75.80% of Royalty Pharma plc stock is owned by institutional investors.
Institutional investors have bought a total of 370.22 M shares in the last 24 months. This purchase volume represents approximately $14.71 B in transactions.